일동제약

249420KOSPI

48.0 / 100

Reference Date: 2026-10-23

Financial Score21.5 / 40

News Sentiment12.5 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 11.0% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Il Dong Pharmaceutical is a company engaged in the manufacture and sale of pharmaceuticals, raw materials, and health supplements. Key products include Aronamin, Furumarin, and Laviert, with sales of 614,941 million won in the 9th fiscal year. Products are distributed domestically and internationally through channels such as wholesale, retail, and hospitals, with active R&D investments.

Number of Employees

1,104people

Average Salary

79.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

13.61Industry Average 15.005.0Point

In line with industry avg

PBR

1.69Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

11.89Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

42.82Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼2.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲86.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -13.0% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 12,820Won52-week high 44,30052-week low 12,150

1-month return1.0Point

1m -11.03% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral타법인주식및출자증권취득결정2026-09-30